FIRST MODIFICATION TO COMMERCIAL PROMISSORY NOTESalix Pharmaceuticals LTD • November 14th, 2003 • Pharmaceutical preparations
THIS FIRST MODIFICATION TO COMMERCIAL PROMISSORY NOTE (“Modification”) is made and entered into this 29th day of September, 2003 by and between SALIX PHARMACEUTICALS, LTD., a Delaware corporation and SALIX PHARMACEUTICALS, INC., a California corporation (collectively, jointly and severally, “Borrower”) and RBC CENTURA BANK (“Bank”).
Portions of this exhibit marked [*] are omitted and are requested to be treated confidentially. DATED October 17, 2003 Glycyx Pharmaceuticals, Ltd. -and- Chong Kun Dang Pharmaceutical CorporationLicense Agreement • November 14th, 2003 • Salix Pharmaceuticals LTD • Pharmaceutical preparations • Delaware
